All products are for research use only. Not for human consumption.
Glycyl-L-histidyl-L-lysine (GHK) is a naturally occurring tripeptide first identified in human plasma in 1973 by Dr. Loren Pickart at the University of California, San Francisco. When complexed with a copper(II) ion (Cu²⁺), it forms GHK-Cu — a peptide-metal complex that has been the subject of over six decades of published research spanning wound healing, collagen biology, anti-inflammatory signaling, and gene expression modulation.
GHK-Cu is found naturally in human plasma, saliva, and urine, with plasma concentrations declining significantly with age — from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. This age-related decline, combined with GHK-Cu's observed biological activities, has made it a subject of particular interest in aging and regenerative research.
Dr. Pickart's initial research demonstrated that a low-molecular-weight factor in young human plasma could stimulate old liver tissue to synthesize proteins at rates comparable to younger tissue. Isolation and characterization of this factor revealed the tripeptide GHK and its high-affinity copper binding properties. Early published studies in Biochemical and Biophysical Research Communications documented GHK-Cu's effects on collagen synthesis, establishing the foundation for decades of subsequent research.
Throughout the 1980s and 1990s, research expanded to include wound-healing models, demonstrating effects on fibroblast activity, angiogenesis, and extracellular matrix remodeling. These foundational studies established GHK-Cu as one of the most extensively documented bioactive peptides in regenerative research literature.
GHK-Cu's effects on wound healing have been documented across multiple preclinical models. Research published in Biomedical Research International and the Journal of Clinical Investigation has demonstrated effects on several key processes: stimulation of collagen types I and III synthesis, increased production of glycosaminoglycans (including decorin, a critical component of the extracellular matrix), enhanced angiogenesis through VEGF and FGF-2 modulation, and nerve growth factor production promoting nerve fiber regeneration.
Studies on dermal fibroblasts have shown GHK-Cu stimulates metalloproteinase activity, which is involved in remodeling damaged extracellular matrix — a critical step in transitioning from inflammatory to proliferative healing phases. This remodeling activity distinguishes GHK-Cu from growth factors that primarily stimulate new tissue production without addressing damaged matrix clearance.
Perhaps the most striking recent research involves GHK-Cu's effects on gene expression. A landmark study using the Broad Institute's Connectivity Map database analyzed GHK-Cu's effects on human gene expression patterns and identified modulation of over 4,000 genes — approximately 6% of the human genome.
The gene expression data revealed that GHK-Cu appeared to reset the expression of multiple genes to patterns associated with younger, healthier tissue. Upregulated pathways included those involved in antioxidant defense (TGM and NQO1 families), DNA repair, collagen synthesis, and anti-inflammatory responses. Downregulated pathways included those associated with fibrosis, inflammation, and tissue degradation.
Preclinical research has demonstrated GHK-Cu's effects on mesenchymal stem cell populations. Studies show increased stem cell attraction to injury sites and enhanced differentiation toward tissue-repair lineages. This stem cell modulation represents a potential mechanism underlying GHK-Cu's observed regenerative effects across diverse tissue types.
Anti-aging research has focused on GHK-Cu's antioxidant properties, its ability to modulate iron levels (reducing oxidative damage catalyzed by free iron), and its effects on proteins associated with cellular senescence. The age-related decline in endogenous GHK-Cu levels has led researchers to investigate whether exogenous GHK-Cu supplementation in research models can reverse age-associated changes in tissue function.
The copper ion in GHK-Cu is not merely a structural component — it is biologically essential. Copper is a cofactor for critical enzymes including superoxide dismutase (antioxidant defense), lysyl oxidase (collagen and elastin cross-linking), and cytochrome c oxidase (mitochondrial function). GHK's high copper-binding affinity (Kd = 10⁻¹⁶·⁴⁴ M) allows it to serve as a bioavailable copper delivery system, potentially modulating intracellular copper levels at target sites.
Active areas of GHK-Cu research include its potential synergistic effects when combined with other regenerative peptides (notably BPC-157 and TB-500), nanoparticle-based delivery systems for enhanced bioavailability, and applications in chronic wound models where standard healing processes are impaired. All GHK-Cu research to date informing these directions has been conducted in preclinical models. For research use only.
GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) complexed with a copper(II) ion. It is found in human plasma, saliva, and urine, with plasma concentrations that decline significantly with age.
Broad Institute Connectivity Map analysis identified over 4,000 human genes modulated by GHK-Cu, representing approximately 6% of the genome. Affected pathways include collagen synthesis, antioxidant defense, DNA repair, and anti-inflammatory signaling.
Copper is biologically essential as a cofactor for enzymes involved in antioxidant defense, collagen cross-linking, and mitochondrial function. GHK's extremely high copper-binding affinity allows it to function as a bioavailable copper delivery system in research models.
Disclaimer: This article is provided for educational and informational purposes only. It does not constitute medical advice. All products referenced are intended strictly for laboratory research use only and are not approved for human consumption.
52 compounds. 99%+ purity. Certificate of Analysis included with every order.